Literature DB >> 32058611

Validity of plasma collection cards for ferritin assessment-A proof-of-concept study.

Karsten Koehler1,2, Eileen Marks-Nelson1, Camila P Braga3, Safiya Beckford1, Jiri Adamec3.   

Abstract

OBJECTIVES: Iron depletion is common around the world and among certain risk groups in developed countries. The overall purpose was to test the suitability of a novel plasma collection card for minimally invasive iron status assessment.
METHODS: Twenty participants (10 f/10 m) participated in this cross-sectional study. Ferritin and hemoglobin were measured from blood collected from a forearm vein, serving as reference method. Blood was also collected from the fingertip using the NoviplexTM Plasma Prep Card as well as capillary collection tubes.
RESULTS: There was substantial concordance between ferritin measured from samples collected via NoviplexTM and venous ferritin (concordance correlation coefficient (CCC) = 0.96) with a mean bias of -0.8 ng/mL. Storing NoviplexTM cards at room temperature for 2 weeks resulted in slightly lower but good concordance when compared to venous ferritin (CCC = 0.95). Capillary hemoglobin (CCC = 0.42) and hematocrit (CCC = 0.25) were in poor agreement with venous data.
CONCLUSIONS: NoviplexTM cards offer a suitable alternative for a minimally invasive ferritin screening in the field when compared to capillary collection tubes. Despite overall substantial concordance with the reference method, findings indicative of iron status abnormalities should be confirmed in venous samples.
© 2020 The Authors. European Journal of Haematology published by John Wiley & Sons Ltd.

Entities:  

Keywords:  capillary blood; ferritin; hemoglobin; iron depletion; iron status; plasma; stability

Mesh:

Substances:

Year:  2020        PMID: 32058611     DOI: 10.1111/ejh.13397

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  2 in total

1.  Use of rapid ferritin test to predict clinical deterioration in at home COVID-19 patients.

Authors:  O Gandini; C Lubrano
Journal:  J Infect       Date:  2020-12-20       Impact factor: 6.072

Review 2.  Role of Polypeptide Inflammatory Biomarkers in the Diagnosis and Monitoring of COVID-19.

Authors:  Aparajita Sen; Arti Nigam; Meenakshi Vachher
Journal:  Int J Pept Res Ther       Date:  2022-01-24       Impact factor: 2.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.